FDA drug approval summa- ry: pegaspargase (oneaspar) for the first-Line treatment of children with acute lymphob|astic leukemia (ALL)

查看全文 作　　者：Patricia AD; Joseph G; Cohen MH; 出　　处：《The Oncologist》索引2007年第12卷第8期,共0页